AbbVie
ABBV
#28
Rank
HK$3.066 T
Marketcap
HK$1,735
Share price
-0.06%
Change (1 day)
29.81%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2025 : HK$534.96 Billion

According to AbbVie's latest financial reports the company's total debt is HK$534.96 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$521.27 B12.39%
2023-12-31HK$463.79 B-6.18%
2022-12-31HK$494.35 B-17.33%
2021-12-31HK$597.94 B-10.37%
2020-12-31HK$667.12 B28.37%
2019-12-31HK$519.68 B64.63%
2018-12-31HK$315.66 B8.12%
2017-12-31HK$291.95 B2.19%
2016-12-31HK$285.69 B16.38%
2015-12-31HK$245.47 B111.31%
2014-12-31HK$116.16 B1.75%
2013-12-31HK$114.16 B-6.02%
2012-12-31HK$121.47 B32484%
2011-12-31HK$0.37 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
HK$473.52 B-11.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$397.20 B-25.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$330.79 B-38.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$424.80 B-20.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$194.09 B-63.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.28 B-90.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$185.69 B-65.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
HK$253.94 B-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$3.33 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA